HSV-1/HSV-2-IN-2
HSV-1/HSV-2-IN-2 is a HSV-1, HSV-2 and VV inhibitor with EC50 values of 6.8, 8.9 and 8.9 µM, respectively. HSV-1/HSV-2-IN-2 shows antiviral activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2490468-39-6
- Formel: C17H14ClFN4OS
- Molecular Weight:376.84
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
IC50 & Target
|
HSV-1 6.8 μM (EC50) |
HSV-2 8.9 μM (EC50) |
In Vitro
HSV-1/HSV-2-IN-2(100 µM, 3-6Days, HEL cell cultures) is effective and nontoxic against HSV-1 (KOS), HSV-2 (G), HSV-1 TK- KOS ACVr and VV at low μM doses[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEL cell cultures
-
Concentration:100 µM
-
Incubation Time:3-6 Days
-
Result:Showed nontoxic and effective at 6.8, 8.9, 6.8 and 8.9 µM against HSV-1 (KOS), HSV-2 (G), HSV-1 TK- KOS ACVr and VV, respectively.
Chemical Information
-
CAS. Nr. 2490468-39-6
-
Molecular Weight 376.84
-
Formel C17H14ClFN4OS
-
SMILES
CCN1C(/C(C2=CC(F)=CC=C21)=N\NC(NC3=CC=CC(Cl)=C3)=S)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
HSV-1/HSV-2-IN-2 Related Classifications
HY-149023 Related Classifications
Powered by Bioz